Evolution of Choroidal Neovascularization due to Presumed Ocular Histoplasmosis Syndrome on Multimodal Imaging including Optical Coherence Tomography Angiography

<div>Fluorescein angiography (late frame) at the patient’s baseline visit (VA 20/70, bevacizumab #1 given) (a); 2-month visit (VA 20/32, bevacizumab #3 given) (b); 4-month visit (VA 20/25) (c); 6-month visit (VA 20/20) (d). After the 2-month visit, there is complete resolution of leakage. VA = visual acuity.</div>

Case Reports in Ophthalmological Medicine

fig4

Figure 4

Figure 4: Evolution of Choroidal Neovascularization due to Presumed Ocular Histoplasmosis Syndrome on Multimodal Imaging including Optical Coherence Tomography Angiography 

Figure 4 | Evolution of Choroidal Neovascularization due to Presumed Ocular Histoplasmosis Syndrome on Multimodal Imaging including Optical Coherence Tomography Angiography 